Searchable abstracts of presentations at key conferences in endocrinology

ea0099oc3.2 | Oral Communications 3: Adrenal and Cardiovascular Endocrinology | Part I | ECE2024

Copeptin and asymptomatic arterial disorder in patients with type 2 diabetes, a cross-sectional study

Davidson Lee Ti , Engvall Jan , Chisalita Simona , Ostgren Carl Johan , Nystrom Fredrik

Background: Individuals with diabetes are at higher risk for developing arterial disorders. The toe-brachial index (TBI) is associated with peripheral vascular disease, and aortic pulse-wave velocity (aPWV) is currently the gold standard for assessing arterial stiffness. High concentrations of plasma arginine vasopressin (AVP) preferentially stimulate V1a receptors, which affect the vascular bed and may contribute to cardiovascular (CV) complications. Copeptin, a more stable p...

ea0077p50 | Metabolism, Obesity and Diabetes | SFEBES2021

Lipocalin 2, a mediator or marker of adipocyte dysfunction?

Parenti Cristina , Lad Nikita , Williams C Neil , Sharpe Graham R , Nelson Carl P , Murphy Alice M , McTernan Philip G

Background: Lipocalin 2 (NGAL) is considered a pro-inflammatory adipokine. Noting the conflicting reports as to the role of Lipocalin 2 in metabolic disease, it remains unclear whether an acute or chronic state affects its impact on adipocyte function. In an attempt to address this our current studies investigated for the first time in humans, whether Lipocalin 2 in abdominal subcutaneous adipose tissue (AT) may influence mitochondrial function and browning of adipocytes, as c...

ea0077p176 | Metabolism, Obesity and Diabetes | SFEBES2021

Asprosin impact on mitochondrial metabolism in obese adipose tissue, a tale of two depots?

Lad Nikita , Murphy Alice M , Parenti Cristina , Nelson Carl P. , Williams Neil C. , Sharpe Graham R. , McTernan Philip G.

Background: In an obese state, pro-inflammatory adipokines can lead to mitochondrial dysfunction and reduced brown adipocytes properties in white adipocytes (BRITE adipocytes), all of which contribute to the pathogenesis of obesity and type 2 diabetes mellitus (T2DM). A recent novel adipokine, asprosin, that influences appetite and glucose homeostasis, appears to drive inflammation in obesity. However, asprosin expression in human adipose tissue (AT) depots, its impact on mito...

ea0084op-02-10 | Oral Session 2: Pregnancy | ETA2022

Phthalate exposure is associated with thyroid function during pregnancy through a novel pathway as a hcg disruptor

Derakhshan Arash , Shu Huan , Broeren Maarten , Demeneix Barbara , H. Lindh Christian , Peeters Robin , Bornehag Carl-Gustaf , Korevaar Tim

Phthalate exposure is associated with thyroid function during pregnancy through a novel pathway as a hCG disruptor.Objectives: hCG stimulates thyroid function in pregnancy and phthalates are known thyroid disruptors. We investigated if phthalate exposure could act as a thyroid disruptor through affecting hCG.Methods: This study was embedded in the prospective Swedish Environmental Longitudinal, Mother and child, Asthma and allergy ...

ea0086p69 | Metabolism, Obesity and Diabetes | SFEBES2022

The effect of novel adipokine asprosin on mitochondrial function in human airway epithelial cells

Lad Nikita , Murphy Alice M , Parenti Cristina , Williams Neil C , Nelson Carl P , Sharpe Graham R , McTernan Philip G

Background: Asprosin is a novel adipokine involved in appetite and glucose regulation. During obesity, circulating asprosin is increased, which leads to increased inflammation and can disrupt cellular functions such as mitochondrial respiration. Asthma is a comorbidity of obesity, with both diseases sharing an inflammatory profile and mitochondrial dysfunction. This study investigated the molecular links between asthma and obesity, by exploring whether asprosin causes mitochon...

ea0041ep706 | Growth hormone IGF axis - basic | ECE2016

The association between neutrophil and lymphocyte ratio in patients diagnosed with acromegaly

Cadırcı Kenan , Kaya Yasemin , Durmaz Şenay , Arslan Abdulmuttalip , Carlıoğlu Ayşe

Aim: İmpaired glucose tolerance and hyperinsulinism/insulin resistance frequently accompany by acromegaly. NLO (Neutrophile lymphocyte ratio) is demonstrated as a simple indicator of systemic inflammation and it is also known that NLO is associated with atherosclerosis progression in coronary artery and a risk factor in coroner artery disease. In this study, we intend to search the association between both coronary atherosclerosis seen frequently in patients diagnosed wi...

ea0070aep52 | Adrenal and Cardiovascular Endocrinology | ECE2020

Ambulance alert system enabling pre-hospital parenteral steroids for patients with adrenal insufficiency

Westall Sam , Sullivan Heather , Rawsthorne Emma , Beesley Carl , Collins John , Furlong Niall , McNulty Steven , Bujawansa Sumudu , Narayanan Ram Prakash

Background: For patients in an adrenal crisis, the timely administration of parenteral hydrocortisone can be life-saving. Data from the Addison’s Disease Self-Help Group found that a large proportion of adrenal crises occur out of hospital, with many patients relying on the emergency services for initial parenteral hydrocortisone administration. Despite regular patient education (including parenteral hydrocortisone self-administration) and recommendations to wear steroid...

ea0028oc1.2 | Young Endocrinologists prize session | SFEBES2012

Structure-function analysis of calcium-sensing receptor (CaSR) mutations reveal clustering at calcium binding sites of the extracellular bilobed venus flytrap domain

Hannan Fadil , Nesbit M Andrew , Zhang Chen , Cranston Treena , Christie Paul , Fratter Carl , Brown Edward , Yang Jenny , Thakker Rajesh

The calcium-sensing receptor (CaSR) is a G protein-coupled receptor with an extracellular bilobed venus flytrap domain (VFTD) predicted to contain five calcium-binding sites. The major site for calcium-binding is comprised of amino acid residues that line the cleft between the two lobes of the VFTD. We investigated the structure-function relationships of VFTD CaSR mutations identified in patients with familial hypocalciuric hypercalcaemia (FHH), neonatal severe primary hyperpa...

ea0056oc4.2 | Novel insights into prediabetes and type 2 diabetes | ECE2018

Toe brachial index predicts major adverse cardiovascular events in patients with type 2 diabetes

Chisalita Ioana Simona , Wijkman Magnus , Chong Lee Ti , Spangeus Anna , Nystrom Fredrik , Ostgren Carl Johan , Lanne Toste

Background: Earlier identification of diabetes patients at high risk of developing cardiovascular complication will help develop new therapeutic targets for the prevention of secondary diseases and death.Objectives: We aim to test the predictive value of toe brachial index (TBI) as a risk marker of major adverse cardiovascular events (MACE) in patients with type 2 diabetes.Methods: TBI was measured in 741 patients with type 2 diabe...